FAILED
首站-论文投稿智能助手
典型文献
Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism
文献摘要:
Worldwide,gastric cancer is the second leading cause of cancer deaths and the fifth most common malig-nant tumor.Gastric cancer is believed to be caused by a variety of factors,such as genetics,epigenetics,and environmental influences.Among the pathogenic factors,inflammation has been considered as one of the main risk factors for gastric cancer.There are currently limited ways to prevent gastric cancer.Although the combined application of aspirin and non-steroidal anti-inflammatory drugs can reduce the risk,it has great side effects and can easily cause gastric perforation or gastric bleeding.Therefore,an alternative plan is urgently needed.Curcumin is the yellow pigment in the rhizome of the plant tur-meric.Current studies have found that curcumin has a protective effect on gastric mucosal damage caused by non-steroidal anti-inflammatory drugs,gastric mucosal damage in rats,and gastric mucosal damage caused by stress bleeding and Helicobacter pylori infection.Curcumin shows significant anti-inflammatory and anti-cancer activities by regulating DNA methylation,histone modification,nuclear factor erythrocyte 2 related factor 2 and other related signal pathways.In this article,the latest evidence of curcumin for epigenetic changes in gastric cancer and its potential contribution to gastric cancer were discussed.
文献关键词:
作者姓名:
Wensen Zhang;Na Cui;Jin Ye;Bingyou Yang;Yanping Sun;Haixue Kuang
作者机构:
Key Laboratory of Chinese Materia Medica,Ministry of Education,Heilongjiang University of Chinese Medicine,Harbin 150040,China
引用格式:
[1]Wensen Zhang;Na Cui;Jin Ye;Bingyou Yang;Yanping Sun;Haixue Kuang-.Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism)[J].中草药(英文版),2022(02):244-253
A类:
B类:
Curcumin,prevention,inflammation,driven,early,gastric,cancer,its,molecular,mechanism,Worldwide,second,leading,deaths,fifth,most,common,malig,nant,tumor,Gastric,believed,caused,by,variety,factors,such,epigenetics,environmental,influences,Among,pathogenic,has,been,considered,main,risk,are,currently,limited,Although,combined,application,aspirin,steroidal,anti,inflammatory,drugs,reduce,great,effects,easily,perforation,bleeding,Therefore,alternative,urgently,needed,yellow,pigment,rhizome,plant,tur,meric,Current,studies,have,found,that,curcumin,protective,mucosal,damage,rats,stress,Helicobacter,pylori,infection,shows,significant,activities,regulating,methylation,histone,modification,nuclear,erythrocyte,related,other,signal,pathways,In,this,article,latest,evidence,changes,potential,contribution,were,discussed
AB值:
0.556502
相似文献
2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment
Zhou Liya;Lu Hong;Song Zhiqiang;Lyu Bin;Chen Ye;Wang Jiyao;Xia Jun;Zhao Zhan-Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China;Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China;Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310018, China;Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;Department of Gastroenterology, Fudan University Affiliated Zhongshan Hospital, Shanghai 200032, China;Nottingham Ningbo GRADE Center, Nottingham China Health Institute, University of Nottingham Ningbo China, Ningbo, Zhejiang 315100, China;Academic Unit of Lifespan and Population Health, School of Medicine, The University of Nottingham, Nottingham, UK;Systematic Review Solutions Ltd, Shanghai 201403, China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。